Endoplasmic reticulum Golgi apparatus targeting micromolecule, conjugate and application of endoplasmic reticulum Golgi apparatus targeting micromolecule
A technology of Golgi apparatus and endoplasmic reticulum, which is applied in the direction of antibody medical ingredients, medical preparations containing active ingredients, carrier-bound antigen/hapten ingredients, etc. Effects of inducing dendritic cells, etc.
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0038] Synthesize diABZI and diABZI-MAL respectively according to the synthetic route shown below.
[0039]
[0040] Reactions and Conditions:
[0041] 1) saturated ammonia water, 25°C, 24h and then 50°C, 4h;
[0042] II) (4-aminobut-2-en-1-yl) tert-butyl carbamate, N, N-diisopropylethylamine (DIPEA), dimethylformamide (DMF), 120°C, 16h, Then trifluoroacetic acid (TFA), dichloromethane (DCM), 25°C, 2h;
[0043] III) boron bromide, DCM, 25°C, 16h;
[0044] IV) 4a: N-(3-chloropropyl)morpholine, DIPEA, DMF, 70°C, 16h or 4b: 4-(3-(tosyloxy)propyl)piperazine-1-carboxylic acid tert Butyl ester, DIPEA, DMF, 80℃, 4h;
[0045] V) DIPEA, isopropanol (IPA) 120 ° C, 16 ~ 24h;
[0046] VI) sodium dithionite, MeOH: water = 4: 3, 25°C, 15min;
[0047] VII) 1-ethyl-3-methyl-1H-pyrazole-5-carbonyl isothiocyanate, DMF / 1,4-dioxane, 0°C, 30min, then 1-(3-dimethyl Aminopropyl)-3-ethylcarbodiimide hydrochloride (EDC), DIPEA, 25°C, 6~14h;
[0048] VIII) 1-ethyl-3-methyl-1H-pyrazole-5-carb...
Embodiment 2
[0079] Example 2: Preparation of diABZI-MAL and polypeptide COVA-i conjugates
[0080]It should be noted that the present invention only provides the preparation of conjugates of diABZI-MAL and polypeptide COVA-i as a schematic example, but the antigens referred to herein that can form conjugates with diABZI-MAL are not limited to The polypeptide, and can be any other antigen known in the art. It should be understood that those skilled in the art can couple other antigens with diABZI-MAL in a similar way to form diABZI-MAL-antigen conjugates.
[0081] For antigens containing cysteine: dissolve the diABZI derivative in dimethylformamide (DMF), dissolve the antigen in a weak alkaline buffer solution, mix in a 1:1 molar ratio, incubate at room temperature for 24 hours, use HPLC Or FPLC separation and purification, concentration and lyophilization into powder.
[0082] Determination of the linked diABZI-antigen conjugate: the product was dissolved in a suitable solvent, and the ...
Embodiment 3
[0087] Example 3: diABZI-COVA-i activation assay and cross-presentation assay
[0088] 1. Preparation of BMDC cells (mouse bone marrow-derived dendritic cells)
[0089] The tibial bone marrow of 4-6-week-old mice (purchased from Guangdong Provincial Animal Center) was dispersed into single cells through a 40 μm cell mesh, and red blood cells were removed with ACK lysate. followed by 1×10 6 / ml bone marrow cells were cultured in RPMI1640 (containing 10% v / v FBS) medium containing 20ng / ml granulocyte-macrophage colony-stimulating factor (GM-CSF) for 2 days, the suspended cells were removed, and new medium was replaced (RPMI1640 (containing 10% v / v FBS) medium containing 20ng / ml granulocyte-macrophage colony-stimulating factor (GM-CSF)) continued to culture for 2 days, then removed the suspended cells and replaced with a new medium (containing 20ng / ml of granulocyte-macrophage colony-stimulating factor (GM-CSF) in RPMI1640 (containing 10% v / v FBS) medium), after continuing to ...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com